Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Melanoma 19Neuroblastoma 16Leukemia 15Prostatic Neoplasms 14Lymphoma 12Multiple Myeloma 10Breast Neoplasms 10Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Acute 8Leukemia, Lymphocytic, Chronic, B-Cell 8Glioblastoma 8Neoplasm Metastasis 6Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Fallopian Tube Neoplasms 6Neoplasms 5Hodgkin Disease 5Carcinoma, Non-Small-Cell Lung 5Uveal Melanoma 4Recurrence 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Kidney Neoplasms 4Glioma 4Carcinoma, Renal Cell 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms, Male 4Ovarian Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3

Interventions

Cyclophosphamide 48fludarabine phosphate 32Peripheral Blood Stem Cell Transplantation 32Whole-Body Irradiation 26Etoposide 23Mycophenolic Acid 22Rituximab 20Filgrastim 18Doxorubicin 18Vincristine 16Cyclosporine 16Busulfan 16Tacrolimus 15Prednisone 15Methotrexate 13Melphalan 13Antilymphocyte Serum 12Cytarabine 11Radiotherapy 10Carboplatin 10Bortezomib 9romidepsin 8Ifosfamide 8Cord Blood Stem Cell Transplantation 8Methylprednisolone 7Lenalidomide 7Flow Cytometry 7Brentuximab Vedotin 7Sirolimus 6Everolimus 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Large-Cell, Anaplastic × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT05544968 2026-04-03

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Medical College of Wisconsin

Phase 1 Recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Neoplasms, Recurrence, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡